Washington
发表于 2025-3-21 16:57:35
书目名称Clinical Management of Acute Lymphoblastic Leukemia影响因子(影响力)<br> http://impactfactor.cn/if/?ISSN=BK0228051<br><br> <br><br>书目名称Clinical Management of Acute Lymphoblastic Leukemia影响因子(影响力)学科排名<br> http://impactfactor.cn/ifr/?ISSN=BK0228051<br><br> <br><br>书目名称Clinical Management of Acute Lymphoblastic Leukemia网络公开度<br> http://impactfactor.cn/at/?ISSN=BK0228051<br><br> <br><br>书目名称Clinical Management of Acute Lymphoblastic Leukemia网络公开度学科排名<br> http://impactfactor.cn/atr/?ISSN=BK0228051<br><br> <br><br>书目名称Clinical Management of Acute Lymphoblastic Leukemia被引频次<br> http://impactfactor.cn/tc/?ISSN=BK0228051<br><br> <br><br>书目名称Clinical Management of Acute Lymphoblastic Leukemia被引频次学科排名<br> http://impactfactor.cn/tcr/?ISSN=BK0228051<br><br> <br><br>书目名称Clinical Management of Acute Lymphoblastic Leukemia年度引用<br> http://impactfactor.cn/ii/?ISSN=BK0228051<br><br> <br><br>书目名称Clinical Management of Acute Lymphoblastic Leukemia年度引用学科排名<br> http://impactfactor.cn/iir/?ISSN=BK0228051<br><br> <br><br>书目名称Clinical Management of Acute Lymphoblastic Leukemia读者反馈<br> http://impactfactor.cn/5y/?ISSN=BK0228051<br><br> <br><br>书目名称Clinical Management of Acute Lymphoblastic Leukemia读者反馈学科排名<br> http://impactfactor.cn/5yr/?ISSN=BK0228051<br><br> <br><br>
AWRY
发表于 2025-3-21 23:18:52
,La régression linéaire multiple,g germline variants that predispose to familial and sporadic ALL, the constellations of genetic changes that define each subtype, and the relationship between genetic variegation, clonal diversity and relapse in ALL. Many of these genetic alterations are of clinical importance as they refine diagnos
amyloid
发表于 2025-3-22 01:46:10
Pierre-André Cornillon,Eric Matzner-Løbera second remission followed by allogeneic hematopoietic stem cell transplantation (HSCT). In recent years, the advent of targeted therapies such as monoclonal antibodies (mAbs) and chimeric antigen receptor (CAR)-T cells, a better understanding of prognostic genomic markers, refined techniques for d
极为愤怒
发表于 2025-3-22 08:37:56
http://reply.papertrans.cn/23/2281/228051/228051_4.png
Virtues
发表于 2025-3-22 09:52:37
http://reply.papertrans.cn/23/2281/228051/228051_5.png
GLARE
发表于 2025-3-22 16:09:49
http://reply.papertrans.cn/23/2281/228051/228051_6.png
GLARE
发表于 2025-3-22 18:41:14
,Theorie ergodique de l’equirepartition,ys and next-generation sequencing technologies, have identified a number of recurrent lesions that can be grouped into several targetable pathways, including Notch, Jak/Stat, MAPK/Ras, PI3K/Akt/mTOR, and cyclin-dependent kinase signaling. Other newer methods to target T-ALL include the use of epigen
Banquet
发表于 2025-3-22 21:20:28
,Theorie ergodique de l’equirepartition,icities, the role of consolidation therapy following CAR T cell therapy, and the development of new cellular products to overcome observed mechanisms of resistance. Here we will review the relevant progress to date with the use of CAR T cells against B-ALL and discuss the limitations and future dire
不要不诚实
发表于 2025-3-23 04:34:02
Molecular Pathways and Targets in B-Cell Progenitor Acute Lymphoblastic Leukemiag germline variants that predispose to familial and sporadic ALL, the constellations of genetic changes that define each subtype, and the relationship between genetic variegation, clonal diversity and relapse in ALL. Many of these genetic alterations are of clinical importance as they refine diagnos
Aggrandize
发表于 2025-3-23 06:39:28
http://reply.papertrans.cn/23/2281/228051/228051_10.png